Optimization of polymer-sulfur asphalt concrete composition for high-temperature pavement applications
Vibroengineering Procedia · 08.06.2026 · 62 · 410-415
DOI: 10.21595/vp.2026.26333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vibroengineering Procedia, online erschienen am 08.06.2026. Verfasst von Alisher Mamatmuminov und 5 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this article, research was conducted on the selection and calculation of the composition of polymer-sulfur asphalt concrete resistant to high-temperature operating conditions. In addition, scientific research was conducted on the granulometric composition and physical and mechanical properties of crushed stone, sand, and mineral powder, which are considered mineral fillers in polymer-sulfur asphalt concrete. As a result of the test processes, 7 different compositions of polymer-sulfur asphalt concrete were developed. This made it possible to determine the physical and mechanical properties of polymer-sulfur asphalt concrete.
Zitieren
APA
Mamatmuminov, A., Sadikov, I., Vasilyev, Y., Sottiqulov, E., Tovboyev, B., & Tilakov, S. (2026). Optimization of polymer-sulfur asphalt concrete composition for high-temperature pavement applications. Vibroengineering Procedia, 62, 410-415. https://doi.org/10.21595/vp.2026.26333
Vancouver
Mamatmuminov A, Sadikov I, Vasilyev Y, Sottiqulov E, Tovboyev B, Tilakov S. Optimization of polymer-sulfur asphalt concrete composition for high-temperature pavement applications. Vibroengineering Procedia. 2026;62:410-415. doi:10.21595/vp.2026.26333
BibTeX
@article{Mamatmuminov2026,
author = {Mamatmuminov, Alisher and Sadikov, Ibragim and Vasilyev, Yuriy and Sottiqulov, Elyor and Tovboyev, Baxrom and Tilakov, Suxrob},
title = {Optimization of polymer-sulfur asphalt concrete composition for high-temperature pavement applications},
journal = {Vibroengineering Procedia},
year = {2026},
volume = {62},
pages = {410--415},
doi = {10.21595/vp.2026.26333}
}
EUVIMED